Erythromycin Estolate Is a Potent Inhibitor Against HCoV-OC43 by Directly Inactivating the Virus Particle. Wang X, Chen Y, Shi H, Zou P, et al. Front Cell Infect Microbiol 2022;12:905248.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang X, Chen Y, Shi H, Zou P, et al. Erythromycin Estolate Is a Potent Inhibitor Against HCoV-OC43 by Directly Inactivating the Virus Particle. Front Cell Infect Microbiol 2022;12:905248.
PMID: 35873167